A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age

Clinical trial NCT02545543 · COMPLETED

Trial details

NCT number: NCT02545543
Sponsor: Seqirus
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2015-09-01
Primary completion: 2016-01-01
Enrollment: 2278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.